WO2005035727A3 - Polymer derivatives - Google Patents
Polymer derivatives Download PDFInfo
- Publication number
- WO2005035727A3 WO2005035727A3 PCT/US2004/033271 US2004033271W WO2005035727A3 WO 2005035727 A3 WO2005035727 A3 WO 2005035727A3 US 2004033271 W US2004033271 W US 2004033271W WO 2005035727 A3 WO2005035727 A3 WO 2005035727A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino acids
- proteins
- azide
- acetylene moiety
- those amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
- C08G65/325—Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
- C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
- C08F216/14—Monomers containing only one unsaturated aliphatic radical
- C08F216/16—Monomers containing no hetero atoms other than the ether oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/02—Alkylation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04794581.1A EP1675620B1 (en) | 2003-10-09 | 2004-10-07 | Polymer derivatives |
EP10195343.8A EP2322569B1 (en) | 2003-10-09 | 2004-10-07 | Polymer derivatives for the selective modification of proteins |
ES04794581T ES2737837T3 (en) | 2003-10-09 | 2004-10-07 | Polymeric derivatives |
JP2006534390A JP4890253B2 (en) | 2003-10-09 | 2004-10-07 | Azide or acetylene-terminated water-soluble polymer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51016903P | 2003-10-09 | 2003-10-09 | |
US60/510,169 | 2003-10-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005035727A2 WO2005035727A2 (en) | 2005-04-21 |
WO2005035727A3 true WO2005035727A3 (en) | 2005-07-28 |
Family
ID=34435064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/033271 WO2005035727A2 (en) | 2003-10-09 | 2004-10-07 | Polymer derivatives |
Country Status (6)
Country | Link |
---|---|
US (5) | US7230068B2 (en) |
EP (2) | EP1675620B1 (en) |
JP (3) | JP4890253B2 (en) |
ES (2) | ES2737837T3 (en) |
SG (2) | SG143252A1 (en) |
WO (1) | WO2005035727A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969526B2 (en) | 2011-03-29 | 2015-03-03 | Roche Glycart Ag | Antibody Fc variants |
US9175083B2 (en) | 2004-06-18 | 2015-11-03 | Ambrx, Inc. | Antigen-binding polypeptides and their uses |
US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
US9434778B2 (en) | 2014-10-24 | 2016-09-06 | Bristol-Myers Squibb Company | Modified FGF-21 polypeptides comprising an internal deletion and uses thereof |
US9540438B2 (en) | 2011-01-14 | 2017-01-10 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
Families Citing this family (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG143252A1 (en) | 2003-10-09 | 2008-06-27 | Ambrx Inc | Polymer derivatives |
NZ586034A (en) * | 2004-02-02 | 2011-10-28 | Ambrx Inc | Modified human growth hormone polypeptides and their uses |
BRPI0512396A (en) * | 2004-07-21 | 2008-03-11 | Ambrx Inc | biosynthetic polypeptides using non-naturally encoded amino acids |
CA2584510C (en) | 2004-10-25 | 2013-05-28 | Intezyne Technologies, Incorporated | Heterobifunctional poly(ethylene glycol) and uses thereof |
EP2325207B1 (en) | 2004-11-12 | 2017-03-15 | Xencor, Inc. | FC variants with altered binding to FCRN |
US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
CA2594557C (en) * | 2004-12-22 | 2016-04-26 | Ambrx, Inc. | Modified human growth hormone |
US7736872B2 (en) | 2004-12-22 | 2010-06-15 | Ambrx, Inc. | Compositions of aminoacyl-TRNA synthetase and uses thereof |
KR101224781B1 (en) | 2004-12-22 | 2013-01-21 | 암브룩스, 인코포레이티드 | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
JP2008525032A (en) | 2004-12-22 | 2008-07-17 | アンブレツクス・インコーポレイテツド | Methods for expressing and purifying recombinant human growth hormone |
US8067006B2 (en) | 2005-04-06 | 2011-11-29 | Immunomedics, Inc. | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
JP2008541769A (en) | 2005-06-03 | 2008-11-27 | アンブレツクス・インコーポレイテツド | Improved human interferon molecules and their use |
KR20080031421A (en) * | 2005-07-18 | 2008-04-08 | 더 스크립스 리서치 인스티튜트 | Method for making amphiphilic dendrimers |
US7301003B2 (en) * | 2005-08-26 | 2007-11-27 | Enzon Pharmaceuticals, Inc. | Method of preparing polymers having terminal amine groups |
CN101454461A (en) | 2005-11-16 | 2009-06-10 | Ambrx公司 | Methods and compositions comprising non-natural amino acids |
CA2642819C (en) | 2006-03-10 | 2015-06-09 | Warwick Effect Polymers Ltd. | Sugar polymers |
WO2007127473A2 (en) * | 2006-04-27 | 2007-11-08 | Intezyne Technologies, Inc. | Poly (ethylene glycol) containing chemically disparate endgroups |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
EP2581450B1 (en) * | 2006-05-02 | 2018-08-15 | MedImmune Limited | Non-natural amino acid substituted polypeptides |
US8242058B2 (en) * | 2006-07-21 | 2012-08-14 | Wisconsin Alumni Research Foundation | Reagents and methods for appending functional groups to proteins |
JP5840345B2 (en) | 2006-09-08 | 2016-01-06 | アンブルックス, インコーポレイテッドAmbrx, Inc. | Modified human plasma polypeptides or modified human Fc scaffold proteins and uses thereof |
MX2009002526A (en) | 2006-09-08 | 2009-04-16 | Ambrx Inc | Suppressor trna transcription in vertebrate cells. |
JP5515224B2 (en) | 2007-02-28 | 2014-06-11 | 日油株式会社 | Multi-branched polyoxyalkylene derivatives |
KR101476472B1 (en) | 2007-03-30 | 2015-01-05 | 암브룩스, 인코포레이티드 | Modified fgf-21 polypeptides and their uses |
NZ580686A (en) * | 2007-05-02 | 2012-11-30 | Ambrx Inc | Modified interferon beta polypeptides and their uses |
US20090047517A1 (en) * | 2007-06-27 | 2009-02-19 | Francesco Caruso | Multilayer polymer films |
CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
US10966431B2 (en) * | 2007-09-11 | 2021-04-06 | Freedom Towel Holdings, LLC. | Refreshment towel and applied solution |
US8182826B2 (en) * | 2007-09-11 | 2012-05-22 | Whitmire A Jeffrey | Refreshment towel and applied solution |
AU2008326324B9 (en) | 2007-11-20 | 2012-11-15 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
US20110124841A1 (en) * | 2007-12-13 | 2011-05-26 | Monthony James F | Polypeptides Modified by Protein Trans-Splicing Technology |
HUE024903T2 (en) | 2007-12-26 | 2016-02-29 | Xencor Inc | Fc variants with altered binding to fcrn |
US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
ES2963062T3 (en) | 2008-07-23 | 2024-03-25 | Ambrx Inc | Modified bovine G-CSF polypeptides and their uses |
US8771642B2 (en) * | 2008-07-31 | 2014-07-08 | Alma Mater Studiorum—Universita' di Bologna | Active particles for bio-analytical applications and methods for their preparation |
BRPI0919403A2 (en) | 2008-09-26 | 2017-09-26 | Ambrx Inc | modified animal erythropoietin polypeptides and their uses |
NZ592249A (en) | 2008-09-26 | 2013-03-28 | Ambrx Inc | Non-natural amino acid replication-dependent microorganisms and vaccines |
JP5913980B2 (en) | 2008-10-14 | 2016-05-11 | ジェネンテック, インコーポレイテッド | Immunoglobulin variants and uses thereof |
CA2742710A1 (en) * | 2008-11-04 | 2010-05-14 | Janssen Pharmaceutica Nv | Crhr2 peptide agonists and uses thereof |
EP2191887A1 (en) * | 2008-11-26 | 2010-06-02 | Polymers CRC Limited | Clickable thin film composite polyamide membranes |
WO2010075548A2 (en) | 2008-12-23 | 2010-07-01 | Genentech, Inc. | Immunoglobulin variants with altered binding to protein a |
WO2010115589A1 (en) | 2009-04-07 | 2010-10-14 | Roche Glycart Ag | Trivalent, bispecific antibodies |
US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
RU2573915C2 (en) | 2009-09-16 | 2016-01-27 | Дженентек, Инк. | Protein complexes containing superhelix and/or banding, and their use |
JP2013510167A (en) * | 2009-11-04 | 2013-03-21 | ヤンセン ファーマシューティカ エヌ.ベー. | Treatment of heart failure with stress-copin-like peptides |
JP5837502B2 (en) * | 2009-11-11 | 2015-12-24 | スリーエム イノベイティブ プロパティズ カンパニー | POLYMER COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND ARTICLE |
WO2011097527A2 (en) | 2010-02-04 | 2011-08-11 | Xencor, Inc. | Immunoprotection of therapeutic moieties using enhanced fc regions |
US20110229528A1 (en) * | 2010-03-12 | 2011-09-22 | Intezyne Technologies, Incorporated | Pegylated polyplexes for polynucleotide delivery |
AR080793A1 (en) | 2010-03-26 | 2012-05-09 | Roche Glycart Ag | BISPECIFIC ANTIBODIES |
EP2605789B1 (en) | 2010-08-17 | 2019-06-05 | Ambrx, Inc. | Modified relaxin polypeptides and their uses |
WO2012025530A1 (en) | 2010-08-24 | 2012-03-01 | F. Hoffmann-La Roche Ag | Bispecific antibodies comprising a disulfide stabilized - fv fragment |
AR083006A1 (en) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME |
WO2012085111A1 (en) | 2010-12-23 | 2012-06-28 | F. Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
JP5768147B2 (en) | 2011-02-28 | 2015-08-26 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Monovalent antigen binding protein |
KR101638224B1 (en) | 2011-02-28 | 2016-07-08 | 에프. 호프만-라 로슈 아게 | Antigen binding proteins |
BR112014019579A2 (en) | 2012-02-10 | 2019-10-15 | Genentech, Inc | SINGLE CHAIN ANTIBODY, POLYNUCLEOTIDE, VECTOR, HOST CELL, METHOD OF PRODUCTION OF A SINGLE CHAIN ANTIBODY, HETEROMULTYMER AND METHOD OF PRODUCTION |
EP2814514B1 (en) | 2012-02-16 | 2017-09-13 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
AR091476A1 (en) | 2012-06-21 | 2015-02-04 | Univ Indiana Res & Tech Corp | REGION FUSION POLYPEPTIDES Fc POLYPEPTIDE BINDING RECEIVER OF INCRETINA AND CONJUGADOS WITH EFECTIVE FUNCTION Fc ALTERED |
CA2871882A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
BR112014032193A2 (en) | 2012-06-27 | 2017-06-27 | Hoffmann La Roche | bispecific antibody production and combination determination methods, bispecific antibody, formulation and use of bispecific antibody |
HRP20211641T1 (en) | 2012-07-13 | 2022-02-04 | Roche Glycart Ag | Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseases |
US20140161790A1 (en) | 2012-11-19 | 2014-06-12 | Xencor, Inc. | Engineered immunoglobulins with extended in vivo half-life |
US9587235B2 (en) | 2013-03-15 | 2017-03-07 | Atyr Pharma, Inc. | Histidyl-tRNA synthetase-Fc conjugates |
EP3587448B1 (en) | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimeric proteins |
US9260527B2 (en) | 2013-03-15 | 2016-02-16 | Sdix, Llc | Anti-human CXCR4 antibodies and methods of making same |
EP3421495A3 (en) | 2013-03-15 | 2019-05-15 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
ES2746136T3 (en) | 2013-04-29 | 2020-03-04 | Hoffmann La Roche | Modified Human FcRn Binding Antibodies and Methods of Use |
RU2019108429A (en) | 2013-04-29 | 2019-05-06 | Ф. Хоффманн-Ля Рош Аг | MODIFIED ASYMMETRIC ANTIBODIES CONNECTING FC-RECEPTOR AND METHODS OF THEIR APPLICATION |
MX2016003593A (en) | 2013-10-11 | 2016-06-02 | Hoffmann La Roche | Multispecific domain exchanged common variable light chain antibodies. |
FR3013712B1 (en) * | 2013-11-22 | 2016-09-09 | Herakles | POLYMERS WITH TERMINAL AZOTURE FUNCTIONS, THEIR OBTAINING; SOLID PROPERGOLS OBTAINED FROM SAID POLYMERS |
CN106029087A (en) | 2013-12-20 | 2016-10-12 | 印第安纳大学研究及科技有限公司 | Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides |
CN110903398B (en) | 2014-01-15 | 2023-08-15 | 豪夫迈·罗氏有限公司 | Fc region variants with modified FCRN and maintained protein A binding properties |
CR20160506A (en) | 2014-03-28 | 2017-03-10 | Xencor Inc | Bispecific Antibodies that bind to CD38 and CD3 |
MX2017005148A (en) | 2014-11-06 | 2017-08-08 | Hoffmann La Roche | Fc-region variants with modified fcrn-binding and methods of use. |
MX2017005150A (en) | 2014-11-06 | 2017-08-08 | Hoffmann La Roche | Fc-region variants with modified fcrn- and protein a-binding properties. |
DK3223845T3 (en) | 2014-11-26 | 2021-08-16 | Xencor Inc | HETERODIMERING ANTIBODIES BINDING CD3 AND CD20 |
US20160176969A1 (en) | 2014-11-26 | 2016-06-23 | Xencor, Inc. | Heterodimeric antibodies including binding to cd8 |
CA2968878A1 (en) | 2014-11-26 | 2016-06-02 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and cd38 |
WO2016087416A1 (en) | 2014-12-03 | 2016-06-09 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
WO2016090157A1 (en) | 2014-12-04 | 2016-06-09 | Celgene Corporation | Biomolecule conjugates |
US10227411B2 (en) | 2015-03-05 | 2019-03-12 | Xencor, Inc. | Modulation of T cells with bispecific antibodies and FC fusions |
AU2016262368B2 (en) | 2015-05-08 | 2019-05-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
EP3313887A2 (en) | 2015-06-26 | 2018-05-02 | MAB Discovery GmbH | Monoclonal anti-il-1racp antibodies |
EP3368568B1 (en) | 2015-10-29 | 2022-04-06 | F. Hoffmann-La Roche AG | Anti-variant fc-region antibodies and methods of use |
CN105330834B (en) * | 2015-10-29 | 2017-10-27 | 江苏中铁奥莱特新材料股份有限公司 | A kind of preparation method of the anti-mud water reducer of side chain terminal groups modification polycarboxylic-acid |
JP2019515677A (en) | 2016-04-26 | 2019-06-13 | アール.ピー.シェーラー テクノロジーズ エルエルシー | Antibody conjugates and methods of making and using the same |
CN109071635B (en) | 2016-05-02 | 2023-09-01 | 豪夫迈·罗氏有限公司 | Contorsbody-single stranded target conjugates |
EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
EP3464370A1 (en) | 2016-06-01 | 2019-04-10 | Xencor, Inc. | Bispecific antibodies that bind cd20 and cd3 for use in the treatment of lymphoma |
WO2017210443A1 (en) | 2016-06-01 | 2017-12-07 | Xencor, Inc. | Bispecific antibodies that bind cd123 and cd3 |
MY194032A (en) | 2016-08-17 | 2022-11-09 | Compugen Ltd | Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof |
WO2018045110A1 (en) | 2016-08-30 | 2018-03-08 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
EP3526241A1 (en) | 2016-10-14 | 2019-08-21 | Xencor, Inc. | Il15/il15r heterodimeric fc-fusion proteins |
US11111305B2 (en) | 2017-01-09 | 2021-09-07 | Torch Therapeutics | Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex |
MX2019008449A (en) | 2017-02-08 | 2019-09-09 | Bristol Myers Squibb Co | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof. |
EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
JP7348072B2 (en) | 2017-06-01 | 2023-09-20 | コンピュジェン リミテッド | Triple combination antibody therapy |
WO2018223004A1 (en) | 2017-06-01 | 2018-12-06 | Xencor, Inc. | Bispecific antibodies that bind cd20 and cd3 |
EP3630839A1 (en) | 2017-06-01 | 2020-04-08 | Xencor, Inc. | Bispecific antibodies that bind cd 123 cd3 |
CN111132733A (en) | 2017-06-30 | 2020-05-08 | Xencor股份有限公司 | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15R α and an antigen binding domain |
WO2019086394A1 (en) | 2017-11-01 | 2019-05-09 | F. Hoffmann-La Roche Ag | The compbody - a multivalent target binder |
CA3086199A1 (en) | 2017-12-19 | 2019-06-27 | Xencor, Inc. | Engineered il-2 fc fusion proteins |
EP3749363A1 (en) | 2018-02-08 | 2020-12-16 | Amgen Inc. | Low ph pharmaceutical antibody formulation |
JP7366056B2 (en) | 2018-04-18 | 2023-10-20 | ゼンコア インコーポレイテッド | A heterodimeric fusion protein targeting LAG-3, comprising an IL-15/IL-15RA Fc fusion protein and a LAG-3 antigen binding domain |
TW202011984A (en) | 2018-04-18 | 2020-04-01 | 美商山可爾股份有限公司 | Il-15/il-15ra heterodimeric fc fusion proteins and uses thereof |
KR20210010862A (en) | 2018-04-18 | 2021-01-28 | 젠코어 인코포레이티드 | IL-15/IL-15Rα Fc-fusion protein and PD-1 targeting heterodimer fusion protein containing PD-1 antigen binding domain and uses thereof |
WO2019204655A1 (en) | 2018-04-18 | 2019-10-24 | Xencor, Inc. | Tim-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and tim-3 antigen binding domains |
TW201945397A (en) | 2018-04-27 | 2019-12-01 | 美商山可爾股份有限公司 | Dosing of a bispecific antibody that bind CD123 and CD3 |
WO2019232484A1 (en) | 2018-06-01 | 2019-12-05 | Compugen Ltd | Anti-pvrig/anti-tigit bispecific antibodies and methods of use |
CA3102256A1 (en) | 2018-06-01 | 2019-12-05 | Novartis Ag | Dosing of a bispecific antibody that bind cd123 and cd3 |
TW202019473A (en) | 2018-07-02 | 2020-06-01 | 美商安進公司 | Anti-steap1 antigen-binding protein |
TW202019965A (en) | 2018-07-16 | 2020-06-01 | 美商安進公司 | Method of treating multiple myeloma |
US20210355275A1 (en) * | 2018-09-28 | 2021-11-18 | Zeon Corporation | Polyether compound and gas separation membrane |
WO2020077276A2 (en) | 2018-10-12 | 2020-04-16 | Xencor, Inc. | Pd-1 targeted il-15/il-15ralpha fc fusion proteins and uses in combination therapies thereof |
WO2020132646A1 (en) | 2018-12-20 | 2020-06-25 | Xencor, Inc. | Targeted heterodimeric fc fusion proteins containing il-15/il-15ra and nkg2d antigen binding domains |
WO2020154540A1 (en) | 2019-01-23 | 2020-07-30 | Millennium Pharmaceuticals, Inc. | Anti-cd38 antibodies |
CN111849122B (en) * | 2019-04-25 | 2022-06-14 | 常熟生益科技有限公司 | Resin composition and application thereof |
TW202128757A (en) | 2019-10-11 | 2021-08-01 | 美商建南德克公司 | Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved properties |
US20230057899A1 (en) | 2019-12-05 | 2023-02-23 | Compugen Ltd. | Anti-pvrig and anti-tigit antibodies for enhanced nk-cell based tumor killing |
EP4087625A4 (en) * | 2020-01-08 | 2024-03-13 | Zepto Life Tech Llc | Polymer compositions and biosurfaces comprising them on sensors |
BR112022014849A2 (en) | 2020-01-28 | 2022-10-11 | Genentech Inc | METHODS OF TREATMENT OF A SOLID TUMOR, METHODS TO INDUCE T-CELL PROLIFERATION, TO INDUCE NK CELL PROLIFERATION AND TO INDUCE IFNY PRODUCTION |
TW202146452A (en) | 2020-02-28 | 2021-12-16 | 瑞士商諾華公司 | Dosing of a bispecific antibody that binds cd123 and cd3 |
CN116472288A (en) | 2020-11-06 | 2023-07-21 | 诺华股份有限公司 | Antibody Fc variants |
JP2023554456A (en) | 2020-12-18 | 2023-12-27 | チューハイ トリノマブ ファーマシューティカル カンパニー リミテッド | Molecule that specifically binds to respiratory syncytial virus |
WO2022140701A1 (en) | 2020-12-24 | 2022-06-30 | Xencor, Inc. | Icos targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and icos antigen binding domains |
IL310372A (en) | 2021-07-28 | 2024-03-01 | Genentech Inc | Il15/il15r alpha heterodimeric fc-fusion proteins for the treatment of blood cancers |
WO2023015198A1 (en) | 2021-08-04 | 2023-02-09 | Genentech, Inc. | Il15/il15r alpha heterodimeric fc-fusion proteins for the expansion of nk cells in the treatment of solid tumours |
CN117858905A (en) | 2021-08-19 | 2024-04-09 | 豪夫迈·罗氏有限公司 | Multivalent anti-variant FC region antibodies and methods of use |
WO2023175498A1 (en) | 2022-03-17 | 2023-09-21 | Pfizer Inc. | Improved igg-degrading enzymes and methods of use thereof |
WO2023196905A1 (en) | 2022-04-07 | 2023-10-12 | Xencor, Inc. | Lag-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and lag-3 antigen binding domains |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5667309A (en) * | 1979-11-02 | 1981-06-06 | Sekisui Chem Co Ltd | Production of photosensitive polymer |
FR2753975A1 (en) * | 1996-10-02 | 1998-04-03 | France Telecom | Compositions containing oxygenated groups used in preparation of solid electrolytes |
US6448369B1 (en) * | 1997-11-06 | 2002-09-10 | Shearwater Corporation | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
US20030096918A1 (en) * | 2001-08-28 | 2003-05-22 | Meldal Morten Peter | Hydroxy and amine functionalised resins |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1245943A (en) * | 1968-08-08 | 1971-09-15 | Ici Ltd | Polyoxyalkylene derivatives |
JPS5855830Y2 (en) | 1978-12-28 | 1983-12-21 | 富士通株式会社 | Heat dissipation structure of electronic equipment |
JPS5592000A (en) * | 1978-12-29 | 1980-07-11 | Chuo Kagaku Kk | Electrolytic cleaning agent composition |
US4289872A (en) | 1979-04-06 | 1981-09-15 | Allied Corporation | Macromolecular highly branched homogeneous compound based on lysine units |
US5597978A (en) * | 1984-12-27 | 1997-01-28 | Aerojet-General Corporation | High energy hydroxy-terminated polyazido polymers |
SU1308594A1 (en) * | 1985-04-15 | 1987-05-07 | Харьковский Автомобильно-Дорожный Институт Им.Комсомола Украины | Method of preparing concrete mix |
DE3675588D1 (en) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
CA1275794C (en) * | 1986-02-28 | 1990-11-06 | Christine Perry | Adducts of propargyl alcohol and their use as corrosion inhibitors in acidizing systems |
US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
CA1322813C (en) * | 1987-06-01 | 1993-10-05 | Edgar R. Wilson | Azide-terminated azido compound |
US5080891A (en) * | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
JPH0439327A (en) * | 1990-06-05 | 1992-02-10 | Nippon Oil & Fats Co Ltd | Azidized polyether having terminal azide group |
US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US5130381A (en) * | 1991-04-05 | 1992-07-14 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government | Branched energetic polyether elastomers |
US5191034A (en) * | 1991-04-05 | 1993-03-02 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Branched energetic polyether elastomers |
US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
US5226957A (en) * | 1992-03-17 | 1993-07-13 | Hewlett-Packard Company | Solubilization of water-insoluble dyes via microemulsions for bleedless, non-threading, high print quality inks for thermal ink-jet printers |
DE69312700T2 (en) | 1992-04-14 | 1998-02-19 | Cornell Res Foundation Inc | MACROMOLECULES BASED ON DENDRITIC POLYMERS AND METHOD FOR THE PRODUCTION THEREOF |
JP3465307B2 (en) * | 1993-08-05 | 2003-11-10 | 日本油脂株式会社 | Polyalkylene oxide derivative and production method |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
JPH07133156A (en) * | 1993-11-08 | 1995-05-23 | Shin Etsu Chem Co Ltd | Slurry composition for casting containing high purify silicon nitride powder |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
CA2136373A1 (en) * | 1993-11-29 | 1995-05-30 | Steven W. Medina | Ethoxylated acetylenic glycols having low dynamic surface tension |
US5650234A (en) | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US5534050A (en) * | 1995-05-25 | 1996-07-09 | Xerox Corporation | Thermal ink jet composition |
US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
DE19532293A1 (en) * | 1995-09-01 | 1997-03-06 | Huels Chemische Werke Ag | Anionic amphiphilic compounds with several hydrophilic and hydrophobic groups based on acetylene derivatives |
FR2743975B1 (en) * | 1996-01-22 | 1998-03-27 | Baliozian Mardick | ELECTRONIC BALLAST SUPPLY AND CONTROL CIRCUIT FOR ILLUMINATION LAMPS |
US5998595A (en) | 1996-11-05 | 1999-12-07 | Wako Pure Chemical Industries, Ltd. | Azidohalogenobenzyl derivatives, sugar compounds and protection of hydroxy groups |
JP3510591B2 (en) * | 1998-03-30 | 2004-03-29 | エルジ ケミカル リミテッド | Polyethoxylated retinamide derivative and method for producing the same |
WO2001062827A2 (en) * | 2000-02-22 | 2001-08-30 | Shearwater Corporation | N-maleimidyl polymer derivatives |
US6723785B2 (en) * | 2000-07-17 | 2004-04-20 | Kao Corporation | Process for preparing aqueous dispersion of pigment-containing polymer particles |
BR0004685B1 (en) * | 2000-10-05 | 2009-01-13 | Method and device for stabilizing the production of oil wells. | |
JP4386156B2 (en) * | 2001-05-30 | 2009-12-16 | 日信化学工業株式会社 | Water-soluble surfactant composition |
JP4758608B2 (en) | 2001-11-07 | 2011-08-31 | ネクター セラピューティックス | Branched polymers and their conjugates |
US7235517B2 (en) * | 2002-12-31 | 2007-06-26 | 3M Innovative Properties Company | Degreasing compositions |
SG143252A1 (en) * | 2003-10-09 | 2008-06-27 | Ambrx Inc | Polymer derivatives |
-
2004
- 2004-10-07 SG SG200803528-9A patent/SG143252A1/en unknown
- 2004-10-07 ES ES04794581T patent/ES2737837T3/en active Active
- 2004-10-07 ES ES10195343T patent/ES2831379T3/en active Active
- 2004-10-07 JP JP2006534390A patent/JP4890253B2/en active Active
- 2004-10-07 SG SG2011081239A patent/SG176455A1/en unknown
- 2004-10-07 EP EP04794581.1A patent/EP1675620B1/en active Active
- 2004-10-07 WO PCT/US2004/033271 patent/WO2005035727A2/en active Application Filing
- 2004-10-07 US US10/960,674 patent/US7230068B2/en active Active
- 2004-10-07 EP EP10195343.8A patent/EP2322569B1/en active Active
-
2007
- 2007-01-24 US US11/657,143 patent/US7737226B2/en active Active
- 2007-01-24 US US11/657,142 patent/US8008428B2/en active Active
-
2010
- 2010-05-06 US US12/775,112 patent/US7820766B2/en active Active
-
2011
- 2011-07-14 US US13/183,343 patent/US9574048B2/en active Active
- 2011-09-29 JP JP2011214487A patent/JP5681605B2/en active Active
-
2014
- 2014-06-10 JP JP2014119464A patent/JP2014208828A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5667309A (en) * | 1979-11-02 | 1981-06-06 | Sekisui Chem Co Ltd | Production of photosensitive polymer |
FR2753975A1 (en) * | 1996-10-02 | 1998-04-03 | France Telecom | Compositions containing oxygenated groups used in preparation of solid electrolytes |
US6448369B1 (en) * | 1997-11-06 | 2002-09-10 | Shearwater Corporation | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
US20030096918A1 (en) * | 2001-08-28 | 2003-05-22 | Meldal Morten Peter | Hydroxy and amine functionalised resins |
Non-Patent Citations (5)
Title |
---|
DATABASE CAPLUS [online] ZALIPSKY ET AL: "Preparation of polyethylene glycol derivatives with two differents functional groups at the terminii.", XP003007916, Database accession no. (1986:406904) * |
GARANTI ET AL: "MeOPEG-bounded azide cycloaddition to alkynyl dipolarophiles.", TETREHEDRON LETTERS., vol. 44, December 2002 (2002-12-01), pages 1133 - 1135, XP004736110 * |
IYER ET AL: "Synthesis of Orthogonal End Functionalized Oligothylene Glycols of Defined Lenghts.", TETRAHEDRON LETTERS., vol. 45, April 2004 (2004-04-01), pages 4285 - 4288, XP004506343 * |
POLYMER REPRINTS., 1986 * |
WILSON ET AL: "Synthesis of Novel Energetic Compounds.", JOURNAL OF CHEMICAL ENGINEERING DATA., vol. 27, May 1982 (1982-05-01), pages 472 - 473, XP002988769 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9175083B2 (en) | 2004-06-18 | 2015-11-03 | Ambrx, Inc. | Antigen-binding polypeptides and their uses |
US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
US9540438B2 (en) | 2011-01-14 | 2017-01-10 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof |
US8969526B2 (en) | 2011-03-29 | 2015-03-03 | Roche Glycart Ag | Antibody Fc variants |
US9434778B2 (en) | 2014-10-24 | 2016-09-06 | Bristol-Myers Squibb Company | Modified FGF-21 polypeptides comprising an internal deletion and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2005035727A2 (en) | 2005-04-21 |
US20100217050A1 (en) | 2010-08-26 |
JP4890253B2 (en) | 2012-03-07 |
ES2737837T3 (en) | 2020-01-16 |
US9574048B2 (en) | 2017-02-21 |
ES2831379T3 (en) | 2021-06-08 |
JP2012031421A (en) | 2012-02-16 |
SG143252A1 (en) | 2008-06-27 |
US20110269974A1 (en) | 2011-11-03 |
US20070123691A1 (en) | 2007-05-31 |
EP2322569A3 (en) | 2016-04-27 |
SG176455A1 (en) | 2011-12-29 |
EP1675620A4 (en) | 2006-12-27 |
US20070123693A1 (en) | 2007-05-31 |
US20050085619A1 (en) | 2005-04-21 |
US7230068B2 (en) | 2007-06-12 |
EP2322569B1 (en) | 2020-08-26 |
EP1675620A2 (en) | 2006-07-05 |
JP2007508427A (en) | 2007-04-05 |
JP5681605B2 (en) | 2015-03-11 |
US7737226B2 (en) | 2010-06-15 |
US7820766B2 (en) | 2010-10-26 |
EP2322569A2 (en) | 2011-05-18 |
US8008428B2 (en) | 2011-08-30 |
JP2014208828A (en) | 2014-11-06 |
EP1675620B1 (en) | 2019-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005035727A3 (en) | Polymer derivatives | |
WO2001075067A3 (en) | Novel nucleic acids and polypeptides | |
WO2001057188A3 (en) | Novel nucleic acids and polypeptides | |
WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
WO2002059260A3 (en) | Nucleic acids and polypeptides | |
WO2002016412A3 (en) | Binding polypeptides for b lymphocyte stimulator protein (blys) | |
WO2002072605A3 (en) | Expression technology for proteins containing a hybrid isotype antibody moiety | |
WO2002008285A3 (en) | Il-17 molecules and uses thereof | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
WO2005059103A3 (en) | Corn plant mon88017 and compositions and methods for detection thereof | |
WO2004080148A3 (en) | Novel nucleic acids and polypeptides | |
WO2003014303A3 (en) | Molecular interactions in cells | |
WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
WO2001068859A3 (en) | Il-17 receptor like molecules and uses thereof | |
WO2004046365A3 (en) | Interferon-alpha polypeptides and conjugates | |
WO1999067382A3 (en) | Angiopoietin-like growth factor sequences | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2001032684A3 (en) | Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww | |
WO2001072822A3 (en) | Genes involved in intestinal inflammatory diseases and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006534390 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004794581 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004794581 Country of ref document: EP |